Quality of life in patients with Ankylosing Spondylitis in Duhok government, Kurdistan of Iraq
DOI:
https://doi.org/10.56056/amj.2024.272Keywords:
Ankylosing spondylitis, Evaluation of Ankylosing Spondylitis Quality of life, Human Leukocyte Antigen B27Abstract
Background and objectives: Spondylarthritis is a broad spectrum of chronic inflammatory diseases, and one of its of phenotypes is ankylosing spondylitis. Ankylosing spondylitis can impact the quality of life and health status because of pain, fatigue, and stiffness. This study aims to evaluate health-related quality of life and extra-articular manifestation in patients with ankylosing spondylitis in Iraq /Duhok city.
Methods: A descriptive cross-sectional study was carried out in the Duhok Center of Rheumatic Diseases. This study was conducted from the first of June 2022 to the end of November 2022 and ninety-two ankylosing spondylitis patients were enrolled and had their quality of life assessed. The assessment of Ankylosing Spondylitis Quality of Life Questionnaire was used, which is divided into four categories: social interaction, emotional health, disease activity, and physical function.
Results: Most of the patients were diagnosed between age 25 and 34 years, more than 90% of the participants were males only 6.5 % were females. The mean value of the total Quality of life score of patients with ankylosing spondylitis was 32.1. %. The patients had bilateral sacroiliitis (90.22%), peripheral arthritis (54.35%), plantar fasciitis (43.48%), and anterior uveitis (22.83%). The HLA-B27 was positive for 60.87% and 93.48% had spinal involvement. A small percentage did moderate physical activity (10.8%). patients with normal sleepers (63.04%), and those who were able to walk (94.57%). The study showed that the total QoL score of short sleepers had worse scores compared to the normal sleepers (41.67 vs. 27.76; P<0001) was statistically significant.
Conclusion: Ankylosing spondylitis is a chronic condition that needs assessment. The disease affects the quality of life, causing functional disability and reduced activity.
Downloads
References
Carron P, De Craemer AS, Van den Bosch F. Peripheral spondyloarthritis: a neglected entity state of the art. RMD Open. 2020. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7299516/
Raychaudhuri S, Deodhar A. The classification and diagnostic criteria of ankylosing spondylitis. J Autoimmun. 2014; 48-49:128-33. https://pubmed.ncbi.nlm.nih.gov/24534717/
Zochling J. Measures of symptoms and disease status in ankylosing spondylitis. Arthritis Care Res. 2011, 63(11). https://pubmed.ncbi.nlm.nih.gov/22588768/
Packham JC, Jordan KP, Haywood KL, Garratt AM, Healey EL. Evaluation of Ankylosing Spondylitis Quality of Life questionnaire: responsiveness of a new patient-reported outcome measure. Rheumatology (Oxford). 2012; 51(4):707-14. https://pubmed.ncbi.nlm.nih.gov/22179735/
Haywood KL, Garratt AM, Jordan KP, Healey EL, Packham JC. Evaluation of ankylosing spondylitis quality of life (EASi-QoL): reliability and validity of a new patient-reported outcome measure. J Rheumatol. 2010 ;37(10):2100-9. https://pubmed.ncbi.nlm.nih.gov/20682667/
Öncülokur N, Keskin D, Garip Y, Bodur H, Köse K. Turkish Version of Evaluation of Ankylosing Spondylitis Quality of Life Questionnaire in patients with Ankylosing Spondylitis:A validation and reliability Study. Arch Rheumatol. 2018 ;33(4):443-54. https://pubmed.ncbi.nlm.nih.gov/30874240/
Tayel MY, Soliman E, El Baz WF, El Labaan A, Hamaad Y, Ahmed MH. Registry of the clinical characteristics of spondyloarthritis in a cohort of Egyptian population. Rheumatol Int. 2012;32(9):2837-42. https://pubmed.ncbi.nlm.nih.gov/21879376/
Otom A, Al-Ahmar MR. HLA-B27 and ankylosing spondylitis in Jordan. GARJMMS. 2013;2(12):252–5. http://garj.org/garjmms/12/2013/2/12/hla-b27-and-ankylosing-spondylitis-in-jordan/
Kim TJ, Kim TH. Clinical spectrum of ankylosing spondylitis in Korea. Joint Bone Spine. 2010; 77(3):23540. https://pubmed.ncbov/203i.nlm.nih.g56776/
Benegas M, Mun˜oz-Gomariz E, Font P, Burgos-Vargas R, Chaves J, Palleiro D et al.Comparison of the clinical expression of patients with ankylosing spondylitis from Europe and Latin America. J Rheumatol. 2012;39(12):231520.
El Mansouri L, Bahiri R, Abourazzak FE, Abouqal R, Hajjaj-Hassouni N. Two distinct patterns of ankylosing spondylitis in Moroccan patients. Rheumatol Int. 2009; 29(12):1423-9. https://pubmed.ncbi.nlm.nih.gov/19259676/
Abdelrahman MH, Mahdy S, Khanjar IA, Siam AM, Malallah HA, Al-Emadi SA, et al. Prevalence of HLA-B27 in Patients with Ankylosing Spondylitis in Qatar. Int J Rheumatol. 2012; 860213. https://www.hindawi.com/journals/ijr/2012/860213/
Abdelhafeez M, Ahmed M, Mohamed R, Ali S. Characterization of ankylosing spondylitis in Upper Egypt. International Journal of Clinical Rheumatology.2018; 13(1): 52-59.https://www.openaccessjournals.com/articles/socioeconomicimpact-/
Rosenbaum JT, Pisenti L, Park Y, Howard RA. Insight into the Quality of Life of Patients with Ankylosing Spondylitis: Real-World Data from a US-Based Life Impact Survey. Rheumatol Ther. 2019;6(3):353-67. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6702589/
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Nahida Zuber Ali, Muhammed Tahir Rasool
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The copyright on any article published in AMJ (The Scientific Journal of Kurdistan Higher Council of Medical Specialties )is retained by the author(s) in agreement with the Creative Commons Attribution Non-Commercial ShareAlike License (CC BY-NC-SA 4.0)
